Showing 2101-2110 of 20880 results for "".
- Overcoming Imatinib Resistance in Gastrointestinal Stromal Tumors: New Frontiers in Precision Medicinehttps://reachmd.com/news/overcoming-imatinib-resistance-in-gastrointestinal-stromal-tumors-new-frontiers-in-precision-medicine/2475745/Oncologists are encountering increasing challenges as Gastrointestinal Stromal Tumors develop resistance to imatinib, necessitating the consideration of alternative tyrosine kinase inhibitors and advanced diagnostic techniques.
- Prognostic Impact of Para-Aortic Lymph Node Metastasis in Endometrial Cancerhttps://reachmd.com/news/prognostic-impact-of-para-aortic-lymph-node-metastasis-in-endometrial-cancer/2475721/A recent comprehensive analysis of risk factors and prognostic implications of para-aortic lymph node metastasis highlights the significant impact of para-aortic invol
- The Role of Genetic Screening and Cardiac Imaging in Diagnosing Transthyretin Amyloidosishttps://reachmd.com/news/the-role-of-genetic-screening-and-cardiac-imaging-in-diagnosing-transthyretin-amyloidosis/2475727/Exploring the pivotal role of genetic screening and cardiac imaging in enhancing the diagnosis of transthyretin amyloidosis. Cardiologists and neurologists increasingly face a diagnostic blind spot where progressive peripheral neuropathy overlaps with cardiac manifestation
- Redefining Gastrointestinal Surgery: Minimally Invasive Innovationshttps://reachmd.com/news/redefining-gastrointestinal-surgery-minimally-invasive-innovations/2475733/Minimally invasive techniques are redefining gastrointestinal surgery, offering safer and more efficient solutions for complex complications such as pouch outlet obstruction following vertical banded gastroplasty.
- Alzheimer’s Diagnostic Innovations: Blood Tests and Vaccine Trialshttps://reachmd.com/news/alzheimers-diagnostic-innovations-blood-tests-and-vaccine-trials/2475707/While the landscape of Alzheimer’s diagnostics is evolving with FDA clearance and innovative vaccine trials, these developments also face challenges such as technological limitations and the need for extensive validation to ensure their effic
- Transformative Molecular and Immune Strategies in Pancreatic Ductal Adenocarcinoma (PDAC)https://reachmd.com/news/transformative-molecular-and-immune-strategies-in-pancreatic-ductal-adenocarcinoma-pdac/2475713/Pancreatic ductal adenocarcinoma’s resilience to conventional chemoradiation demands a paradigm shift toward targeted molecular and immune-based interventions. Despite incremental advances, PDAC prognosis remains dismal, with a five-ye
- Evolving Strategies in Managing Electrolyte Imbalance and Arrhythmia Drugs for Atrial Fibrillationhttps://reachmd.com/news/evolving-strategies-in-managing-electrolyte-imbalance-and-arrhythmia-drugs-for-atrial-fibrillation/2475716/A recent analysis has revealed that even modest hyponatremia can blunt flecainide’s antiarrhythmic effect, exposing a critical blind spot in atrial fibrillation management that demands immediate attention from cardiologists. As atrial
- Emerging Role of Epac1 in Idiopathic Pulmonary Fibrosis Managementhttps://reachmd.com/news/emerging-role-of-epac1-in-idiopathic-pulmonary-fibrosis-management/2475708/Underrecognized drivers of fibrosis like Epac1 may hold the key to more effective interventions in idiopathic pulmonary fibrosis (IPF), yet its therapeutic potential remains unfamiliar to many pulmonologists. Idiopathic pulmonary fibro
- Emerging Fronts in Combatting Multidrug-Resistant Infections: Insights from Ghana, Ethiopia, and Novel Burn Care Innovationshttps://reachmd.com/news/emerging-fronts-in-combatting-multidrug-resistant-infections-insights-from-ghana-ethiopia-and-novel-burn-care-innovations/2475692/Recent surveillance revealed a surge of multidrug-resistant genitourinary infections in the Volta Region of Ghana, rampant ESBL gene dissemination in Ethiopia, and novel dermal substitutes showing antimicrobial promise in burn care. As
- Revolutionizing CRS Management: The Promise of Intranasal Monoclonal Antibody Therapyhttps://reachmd.com/news/revolutionizing-crs-management-the-promise-of-intranasal-monoclonal-antibody-therapy/2475693/For the otolaryngologist managing recalcitrant chronic rhinosinusitis (CRS) in patients beset by persistent sinonasal obstruction and allergy-driven flares, the multifaceted interplay of mucosal inflammation and atopy demands novel strategies